Today CeMM is home to 9 Principal Investigators and 10 Adjunct Principal Investigators who focus on fundamental questions in molecular medicine. The Principal Investigators include six recipients of prestigious ERC grants (Starting Grants: Christoph Bock, Andreas Bergthaler, Kaan Boztug, Sebastian Nijman, Thijn Brummelkamp; Consolidator Grants: Kaan Boztug, Stefan Kubicek; and Advanced Investigator Grant: Giulio Superti-Furga) and one Innovative Medicines Initiative - IMI Resolute - Grant (Giulio Superti-Furga).
Together we pioneer science that nurtures precise, personalized, predictive and preventative medicine
In keeping with CeMM´s mission to pioneer the science that nurtures the precise, personalized, predictive and preventive medicine of the future, we have a strong connection to clinics. 2 CeMM Principal Investigators (Christoph Binder, Sylvia Knapp) and 4 Adjunct Principal Investigators (Kate Ackerman, Kaan Boztug, Thomas Reiberger, Georg Stary) hold Medical Degrees and are performing clinical work alongside their scientific research. In total 8 CeMM Prinicipal Investigators have a dual affiliation with the Medical University of Vienna (Christoph Binder, Christoph Bock, Kaan Boztug, Sylvia Knapp, Robert Kralovics, Thomas Reiberger, Georg Stary and Giulio Superti-Furga).